We are live on ! Find out more
NI

Nepsis Inc Portfolio holdings

AUM $295M
1-Year Est. Return 35.44%
This Fund
S&P 500
This Quarter Est. Return
+9.21%
1 Year Est. Return
+35.44%
3 Year Est. Return
+115.51%
5 Year Est. Return
+196.69%
10 Year Est. Return
+848.99%
AUM
$422M
AUM Growth
+$51M
Cap. Flow
+$28.5M
Cap. Flow %
6.75%
Top 10 Hldgs %
50.87%
Holding
30
New
2
Increased
23
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$17.5M
2
ORCL icon
Oracle
ORCL
+$10.9M
3
VKTX icon
Viking Therapeutics
VKTX
+$10.4M
4
HCAT icon
Health Catalyst
HCAT
+$6.15M
5
BMY icon
Bristol-Myers Squibb
BMY
+$3.05M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$20.3M
2
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
+$19.9M
3
QCOM icon
Qualcomm
QCOM
+$3.76M
4
GIS icon
General Mills
GIS
+$63.3K
5
DUK icon
Duke Energy
DUK
+$18.8K

Sector Composition

Rank Sector Weight
1 Financials 29.25%
2 Technology 27.32%
3 Healthcare 20.61%
4 Energy 7.95%
5 Consumer Discretionary 4.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNR icon
1
RenaissanceRe
RNR
$13.3B
$26.4M 6.27%
97,068
+5,996
+7% +$1.45M
AMD icon
2
Advanced Micro Devices
AMD
$776B
$26.2M 6.21%
159,673
+5,297
+3% +$805K
SHOP icon
3
Shopify
SHOP
$152B
$25.9M 6.14%
323,259
+14,452
+5% +$998K
CB icon
4
Chubb
CB
$135B
$21.4M 5.07%
74,125
+3,323
+5% +$911K
AIG icon
5
American International
AIG
$41.7B
$19.7M 4.66%
268,334
+6,196
+2% +$462K
RLI icon
6
RLI Corp
RLI
$5.62B
$19.2M 4.56%
248,312
+39,880
+19% +$2.95M
AMGN icon
7
Amgen
AMGN
$208B
$19.2M 4.56%
59,715
+3,735
+7% +$1.22M
DVN icon
8
Devon Energy
DVN
$52.1B
$19M 4.51%
486,781
+46,216
+10% +$2.03M
MA icon
9
Mastercard
MA
$506B
$19M 4.5%
38,483
+1,829
+5% +$851K
UTHR icon
10
United Therapeutics
UTHR
$25.8B
$18.6M 4.4%
+51,808
New +$17.5M
CAVA icon
11
CAVA Group
CAVA
$7.6B
$18.3M 4.33%
147,507
+6,380
+5% +$648K
V icon
12
Visa
V
$684B
$17.7M 4.2%
64,392
+4,091
+7% +$1.11M
HCAT icon
13
Health Catalyst
HCAT
$154M
$17.1M 4.06%
2,104,528
+851,448
+68% +$6.15M
CI icon
14
Cigna
CI
$73.8B
$17.1M 4.06%
49,435
+3,394
+7% +$1.17M
QCOM icon
15
Qualcomm
QCOM
$155B
$16.7M 3.97%
98,427
-21,307
-18% -$3.76M
CYBR
16
DELISTED
CyberArk
CYBR
$16.7M 3.96%
57,239
+1,595
+3% +$432K
AMAT icon
17
Applied Materials
AMAT
$403B
$16.5M 3.92%
81,908
+13,659
+20% +$2.8M
FANG icon
18
Diamondback Energy
FANG
$57.1B
$14.5M 3.43%
84,065
+1,103
+1% +$212K
WBD icon
19
Warner Bros
WBD
$65.9B
$14M 3.33%
1,702,350
+269,584
+19% +$2.11M
ORCL icon
20
Oracle
ORCL
$374B
$13.2M 3.13%
77,394
+74,966
+3,088% +$10.9M
IRM icon
21
Iron Mountain
IRM
$36.4B
$11.5M 2.72%
96,582
+26,331
+37% +$2.82M
VKTX icon
22
Viking Therapeutics
VKTX
$3.7B
$11.3M 2.67%
+177,714
New +$10.4M
NHI icon
23
National Health Investors
NHI
$3.72B
$5.7M 1.35%
67,808
+10,820
+19% +$834K
SO icon
24
Southern Company
SO
$109B
$4.44M 1.05%
49,180
+7,925
+19% +$677K
GIS icon
25
General Mills
GIS
$19.1B
$4.43M 1.05%
60,042
-914
-1% -$63.3K
1
2

Similar funds

CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
PC
Permit Capital West Conshohocken, Pennsylvania $294M AUM 27.9% 1-Year Est. Return
SM
Selkirk Management Chatham, New Jersey $294M AUM 26.84% 1-Year Est. Return
BIC
B&I Capital Zurich, Switzerland $294M AUM 3.09% 1-Year Est. Return
TJHA
Thomas J. Herzfeld Advisors Miami Beach, Florida $294M AUM 2.62% 1-Year Est. Return
FRA
Front Row Advisors Tiburon, California $296M AUM 34.73% 1-Year Est. Return
SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return

Nepsis Inc's Q3 2024 Portfolio in Review

As of Q3 2024, Nepsis Inc held 30 positions worth $422M, up 14% from $371M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Nepsis Inc deployed $28.5M of net new capital in Q3 2024, opening 2 new positions and adding to 23 existing holdings. Its largest new stake was United Therapeutics: 51,808 shares worth $18.6M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $20.3M trimmed.

  • Nepsis Inc's largest Q3 2024 buy was United Therapeutics: 51,808 shares worth $18.6M.
  • Nepsis Inc added most to Oracle in Q3 2024, an estimated $10.9M increase.
  • Nepsis Inc's biggest Q3 2024 reduction was Alphabet (Google) Class C, cutting an estimated $20.3M.
  • Nepsis Inc fully exited PetIQ, Inc. Class A Common Stock in Q3 2024, selling an estimated $19.9M.
  • Nepsis Inc's ten largest holdings make up 51% of its $422M portfolio in Q3 2024.
  • Nepsis Inc opened 2 new positions and closed 1 in Q3 2024.
  • Nepsis Inc's portfolio value rose 14% quarter-over-quarter to $422M.

Based on Nepsis Inc's 13F filing for Q3 2024, filed 18 Oct 2024.